Aspirin and Microcytic anaemia - a phase IV clinical study of FDA data
We study 590,931 people who have side effects when taking Aspirin. Microcytic anaemia is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Xarelto and have Atrial fibrillation/flutter.
The phase IV clinical study analyzes which people take Aspirin and have Microcytic anaemia. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
590,931 people reported to have side effects when taking Aspirin.
Among them, 219 people (0.04%) have Microcytic anaemia.
What is Aspirin?
Aspirin has active ingredients of aspirin. It is used in blood clots. Currently, eHealthMe is studying from 600,584 Aspirin users.
What is Microcytic anaemia?
Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells) is found to be associated with 901 drugs and 480 conditions by eHealthMe. Currently, we are studying 3,008 people who have Microcytic anaemia.
Number of Aspirin and Microcytic anaemia reports submitted per year:
Time on Aspirin when people have Microcytic anaemia *:
Gender of people who have Microcytic anaemia when taking Aspirin*:
Age of people who have Microcytic anaemia when taking Aspirin *:
Common drugs people take besides Aspirin *:
Common side effects people have besides Microcytic anaemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Aspirin and have Microcytic anaemia?Check whether Microcytic anaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
Aspirin side effects by duration, gender and age:
- Aspirin side effects (600,584 reports)
Microcytic anaemia treatments and more:
- Microcytic anaemia (3,008 reports)
Common drugs associated with Microcytic anaemia:
- Aspirin: 219 reports
- Xarelto: 195 reports
- Lasix: 189 reports
- Prednisone: 182 reports
- Metformin: 160 reports
- Omeprazole: 143 reports
- Accutane: 133 reports
- Profen: 124 reports
- Ibu: 124 reports
- Furosemide: 120 reports
All the drugs that are associated with Microcytic anaemia:
- Microcytic anaemia (901 drugs)
Common conditions associated with Microcytic anaemia:
- Atrial fibrillation/flutter: 242 reports
- High blood pressure: 204 reports
- Rheumatoid arthritis: 151 reports
- Stroke: 121 reports
All the conditions that are associated with Microcytic anaemia:
- Microcytic anaemia (480 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aspirin (the active ingredients of Aspirin) and Aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Perindopril Erbumine and Zyvox drug interaction - 2 seconds ago
- Vascepa and Trilipix drug interaction - 5 seconds ago
- Profen and Microcytic Anaemia - 5 seconds ago
- Lasix and Microcytic Anaemia - 8 seconds ago
- Olmesartan Medoxomil and Armodafinil drug interaction - 25 seconds ago
- Anusol Hc and Pneumonia - 41 seconds ago
- Senna and Cefuroxime Sodium drug interaction - a minute ago
- Cyclophosphamide and Alveolar Osteitis - a minute ago
- Brimonidine Tartrate and Cardiac Arrest - a minute ago
- Metoprolol Tartrate and Flecainide Acetate drug interaction - a minute ago